Galactose epimerase deficiency: lessons from the GalNet registry

Autores
Derks, Britt; Demirbas, Didem; Arantes, Rodrigo R.; Banford, Samantha; Burlina, Alberto B.; Cabrera, Analía; Chiesa, Ana Elena; Couce, M. Luz; Dionisi Vici, Carlo; Gautschi, Matthias; Grünewald, Stephanie; Morava, Eva; Möslinger, Dorothea; Scholl Bürgi, Sabine; Skouma, Anastasia; Stepien, Karolina M.; Timson, David J.; Berry, Gerard T.; Rubio Gozalbo, M. Estela
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Galactose epimerase (GALE) deficiency is a rare hereditary disorder of galactose metabolism with only a few cases described in the literature. This study aims to present the data of patients with GALE deficiency from different countries included through the Galactosemia Network to further expand the existing knowledge and review the current diagnostic strategy, treatment and follow-up of this not well characterized entity. Methods: Observational study collecting medical data from December 2014 to April 2022 of 22 not previously reported patients from 14 centers in 9 countries. Patients were classified as generalized or non-generalized based on their genotype, enzyme activities in different tissues and/or clinical picture and professional judgment of the treating physician. Results: In total 6 patients were classified as generalized and 16 as non-generalized. In the generalized group, acute neonatal illness was reported in 3, cognitive and developmental delays were present in 5 and hearing problems were reported in 3. Four generalized patients were homozygous for the genetic variant NM_001008216.2:c.280G > A (p.Val94Met). In the non-generalized group, no clearly related symptoms were found. Ten novel genetic variants were reported in this study population. Conclusion: The phenotypic spectrum of GALE deficiency ranges from asymptomatic to severe. The generalized patients have a phenotype that is in line with the 9 described cases in the literature and prescribing dietary interventions is the cornerstone for treatment. In the non-generalized group, treatment advice is more difficult. To be able to offer proper counseling, in addition to red blood cell enzyme activity, genetic studies, transferrin glycoform analysis and enzymatic measurements in fibroblasts are recommended. Due to lack of facilities, additional enzymatic testing is not common practice in many centers nor a tailored long-term follow-up is performed.
Fil: Derks, Britt. Universiteit Maastricht.; Países Bajos
Fil: Demirbas, Didem. Boston Children’s Hospital; Estados Unidos
Fil: Arantes, Rodrigo R.. Universidade Federal de Minas Gerais; Brasil
Fil: Banford, Samantha. No especifíca;
Fil: Burlina, Alberto B.. No especifíca;
Fil: Cabrera, Analía. Hospital de Niños V.J. Vilela; Argentina
Fil: Chiesa, Ana Elena. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Couce, M. Luz. No especifíca;
Fil: Dionisi Vici, Carlo. No especifíca;
Fil: Gautschi, Matthias. University of Bern; Suiza
Fil: Grünewald, Stephanie. Colegio Universitario de Londres; Reino Unido
Fil: Morava, Eva. No especifíca;
Fil: Möslinger, Dorothea. Medizinische Universität Wien; Austria
Fil: Scholl Bürgi, Sabine. No especifíca;
Fil: Skouma, Anastasia. No especifíca;
Fil: Stepien, Karolina M.. No especifíca;
Fil: Timson, David J.. University Of Brighton; Reino Unido
Fil: Berry, Gerard T.. Boston Children’s Hospital; Estados Unidos
Fil: Rubio Gozalbo, M. Estela. Universiteit Maastricht.; Países Bajos
Materia
GALACTOSE EPIMERASE DEFICIENCY
GALACTOSE-RESTRICTED DIET
GALACTOSEMIA TYPE III
GALACTOSEMIAS NETWORK
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/213633

id CONICETDig_45aba99c7ed0fd398237318a554d8b2d
oai_identifier_str oai:ri.conicet.gov.ar:11336/213633
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Galactose epimerase deficiency: lessons from the GalNet registryDerks, BrittDemirbas, DidemArantes, Rodrigo R.Banford, SamanthaBurlina, Alberto B.Cabrera, AnalíaChiesa, Ana ElenaCouce, M. LuzDionisi Vici, CarloGautschi, MatthiasGrünewald, StephanieMorava, EvaMöslinger, DorotheaScholl Bürgi, SabineSkouma, AnastasiaStepien, Karolina M.Timson, David J.Berry, Gerard T.Rubio Gozalbo, M. EstelaGALACTOSE EPIMERASE DEFICIENCYGALACTOSE-RESTRICTED DIETGALACTOSEMIA TYPE IIIGALACTOSEMIAS NETWORKhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Galactose epimerase (GALE) deficiency is a rare hereditary disorder of galactose metabolism with only a few cases described in the literature. This study aims to present the data of patients with GALE deficiency from different countries included through the Galactosemia Network to further expand the existing knowledge and review the current diagnostic strategy, treatment and follow-up of this not well characterized entity. Methods: Observational study collecting medical data from December 2014 to April 2022 of 22 not previously reported patients from 14 centers in 9 countries. Patients were classified as generalized or non-generalized based on their genotype, enzyme activities in different tissues and/or clinical picture and professional judgment of the treating physician. Results: In total 6 patients were classified as generalized and 16 as non-generalized. In the generalized group, acute neonatal illness was reported in 3, cognitive and developmental delays were present in 5 and hearing problems were reported in 3. Four generalized patients were homozygous for the genetic variant NM_001008216.2:c.280G > A (p.Val94Met). In the non-generalized group, no clearly related symptoms were found. Ten novel genetic variants were reported in this study population. Conclusion: The phenotypic spectrum of GALE deficiency ranges from asymptomatic to severe. The generalized patients have a phenotype that is in line with the 9 described cases in the literature and prescribing dietary interventions is the cornerstone for treatment. In the non-generalized group, treatment advice is more difficult. To be able to offer proper counseling, in addition to red blood cell enzyme activity, genetic studies, transferrin glycoform analysis and enzymatic measurements in fibroblasts are recommended. Due to lack of facilities, additional enzymatic testing is not common practice in many centers nor a tailored long-term follow-up is performed.Fil: Derks, Britt. Universiteit Maastricht.; Países BajosFil: Demirbas, Didem. Boston Children’s Hospital; Estados UnidosFil: Arantes, Rodrigo R.. Universidade Federal de Minas Gerais; BrasilFil: Banford, Samantha. No especifíca;Fil: Burlina, Alberto B.. No especifíca;Fil: Cabrera, Analía. Hospital de Niños V.J. Vilela; ArgentinaFil: Chiesa, Ana Elena. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Couce, M. Luz. No especifíca;Fil: Dionisi Vici, Carlo. No especifíca;Fil: Gautschi, Matthias. University of Bern; SuizaFil: Grünewald, Stephanie. Colegio Universitario de Londres; Reino UnidoFil: Morava, Eva. No especifíca;Fil: Möslinger, Dorothea. Medizinische Universität Wien; AustriaFil: Scholl Bürgi, Sabine. No especifíca;Fil: Skouma, Anastasia. No especifíca;Fil: Stepien, Karolina M.. No especifíca;Fil: Timson, David J.. University Of Brighton; Reino UnidoFil: Berry, Gerard T.. Boston Children’s Hospital; Estados UnidosFil: Rubio Gozalbo, M. Estela. Universiteit Maastricht.; Países BajosBioMed Central2022-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/213633Derks, Britt; Demirbas, Didem; Arantes, Rodrigo R.; Banford, Samantha; Burlina, Alberto B.; et al.; Galactose epimerase deficiency: lessons from the GalNet registry; BioMed Central; Orphanet Journal Of Rare Diseases; 17; 1; 12-2022; 1-121750-1172CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/s13023-022-02494-4info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:21:16Zoai:ri.conicet.gov.ar:11336/213633instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:21:16.507CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Galactose epimerase deficiency: lessons from the GalNet registry
title Galactose epimerase deficiency: lessons from the GalNet registry
spellingShingle Galactose epimerase deficiency: lessons from the GalNet registry
Derks, Britt
GALACTOSE EPIMERASE DEFICIENCY
GALACTOSE-RESTRICTED DIET
GALACTOSEMIA TYPE III
GALACTOSEMIAS NETWORK
title_short Galactose epimerase deficiency: lessons from the GalNet registry
title_full Galactose epimerase deficiency: lessons from the GalNet registry
title_fullStr Galactose epimerase deficiency: lessons from the GalNet registry
title_full_unstemmed Galactose epimerase deficiency: lessons from the GalNet registry
title_sort Galactose epimerase deficiency: lessons from the GalNet registry
dc.creator.none.fl_str_mv Derks, Britt
Demirbas, Didem
Arantes, Rodrigo R.
Banford, Samantha
Burlina, Alberto B.
Cabrera, Analía
Chiesa, Ana Elena
Couce, M. Luz
Dionisi Vici, Carlo
Gautschi, Matthias
Grünewald, Stephanie
Morava, Eva
Möslinger, Dorothea
Scholl Bürgi, Sabine
Skouma, Anastasia
Stepien, Karolina M.
Timson, David J.
Berry, Gerard T.
Rubio Gozalbo, M. Estela
author Derks, Britt
author_facet Derks, Britt
Demirbas, Didem
Arantes, Rodrigo R.
Banford, Samantha
Burlina, Alberto B.
Cabrera, Analía
Chiesa, Ana Elena
Couce, M. Luz
Dionisi Vici, Carlo
Gautschi, Matthias
Grünewald, Stephanie
Morava, Eva
Möslinger, Dorothea
Scholl Bürgi, Sabine
Skouma, Anastasia
Stepien, Karolina M.
Timson, David J.
Berry, Gerard T.
Rubio Gozalbo, M. Estela
author_role author
author2 Demirbas, Didem
Arantes, Rodrigo R.
Banford, Samantha
Burlina, Alberto B.
Cabrera, Analía
Chiesa, Ana Elena
Couce, M. Luz
Dionisi Vici, Carlo
Gautschi, Matthias
Grünewald, Stephanie
Morava, Eva
Möslinger, Dorothea
Scholl Bürgi, Sabine
Skouma, Anastasia
Stepien, Karolina M.
Timson, David J.
Berry, Gerard T.
Rubio Gozalbo, M. Estela
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv GALACTOSE EPIMERASE DEFICIENCY
GALACTOSE-RESTRICTED DIET
GALACTOSEMIA TYPE III
GALACTOSEMIAS NETWORK
topic GALACTOSE EPIMERASE DEFICIENCY
GALACTOSE-RESTRICTED DIET
GALACTOSEMIA TYPE III
GALACTOSEMIAS NETWORK
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: Galactose epimerase (GALE) deficiency is a rare hereditary disorder of galactose metabolism with only a few cases described in the literature. This study aims to present the data of patients with GALE deficiency from different countries included through the Galactosemia Network to further expand the existing knowledge and review the current diagnostic strategy, treatment and follow-up of this not well characterized entity. Methods: Observational study collecting medical data from December 2014 to April 2022 of 22 not previously reported patients from 14 centers in 9 countries. Patients were classified as generalized or non-generalized based on their genotype, enzyme activities in different tissues and/or clinical picture and professional judgment of the treating physician. Results: In total 6 patients were classified as generalized and 16 as non-generalized. In the generalized group, acute neonatal illness was reported in 3, cognitive and developmental delays were present in 5 and hearing problems were reported in 3. Four generalized patients were homozygous for the genetic variant NM_001008216.2:c.280G > A (p.Val94Met). In the non-generalized group, no clearly related symptoms were found. Ten novel genetic variants were reported in this study population. Conclusion: The phenotypic spectrum of GALE deficiency ranges from asymptomatic to severe. The generalized patients have a phenotype that is in line with the 9 described cases in the literature and prescribing dietary interventions is the cornerstone for treatment. In the non-generalized group, treatment advice is more difficult. To be able to offer proper counseling, in addition to red blood cell enzyme activity, genetic studies, transferrin glycoform analysis and enzymatic measurements in fibroblasts are recommended. Due to lack of facilities, additional enzymatic testing is not common practice in many centers nor a tailored long-term follow-up is performed.
Fil: Derks, Britt. Universiteit Maastricht.; Países Bajos
Fil: Demirbas, Didem. Boston Children’s Hospital; Estados Unidos
Fil: Arantes, Rodrigo R.. Universidade Federal de Minas Gerais; Brasil
Fil: Banford, Samantha. No especifíca;
Fil: Burlina, Alberto B.. No especifíca;
Fil: Cabrera, Analía. Hospital de Niños V.J. Vilela; Argentina
Fil: Chiesa, Ana Elena. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Couce, M. Luz. No especifíca;
Fil: Dionisi Vici, Carlo. No especifíca;
Fil: Gautschi, Matthias. University of Bern; Suiza
Fil: Grünewald, Stephanie. Colegio Universitario de Londres; Reino Unido
Fil: Morava, Eva. No especifíca;
Fil: Möslinger, Dorothea. Medizinische Universität Wien; Austria
Fil: Scholl Bürgi, Sabine. No especifíca;
Fil: Skouma, Anastasia. No especifíca;
Fil: Stepien, Karolina M.. No especifíca;
Fil: Timson, David J.. University Of Brighton; Reino Unido
Fil: Berry, Gerard T.. Boston Children’s Hospital; Estados Unidos
Fil: Rubio Gozalbo, M. Estela. Universiteit Maastricht.; Países Bajos
description Background: Galactose epimerase (GALE) deficiency is a rare hereditary disorder of galactose metabolism with only a few cases described in the literature. This study aims to present the data of patients with GALE deficiency from different countries included through the Galactosemia Network to further expand the existing knowledge and review the current diagnostic strategy, treatment and follow-up of this not well characterized entity. Methods: Observational study collecting medical data from December 2014 to April 2022 of 22 not previously reported patients from 14 centers in 9 countries. Patients were classified as generalized or non-generalized based on their genotype, enzyme activities in different tissues and/or clinical picture and professional judgment of the treating physician. Results: In total 6 patients were classified as generalized and 16 as non-generalized. In the generalized group, acute neonatal illness was reported in 3, cognitive and developmental delays were present in 5 and hearing problems were reported in 3. Four generalized patients were homozygous for the genetic variant NM_001008216.2:c.280G > A (p.Val94Met). In the non-generalized group, no clearly related symptoms were found. Ten novel genetic variants were reported in this study population. Conclusion: The phenotypic spectrum of GALE deficiency ranges from asymptomatic to severe. The generalized patients have a phenotype that is in line with the 9 described cases in the literature and prescribing dietary interventions is the cornerstone for treatment. In the non-generalized group, treatment advice is more difficult. To be able to offer proper counseling, in addition to red blood cell enzyme activity, genetic studies, transferrin glycoform analysis and enzymatic measurements in fibroblasts are recommended. Due to lack of facilities, additional enzymatic testing is not common practice in many centers nor a tailored long-term follow-up is performed.
publishDate 2022
dc.date.none.fl_str_mv 2022-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/213633
Derks, Britt; Demirbas, Didem; Arantes, Rodrigo R.; Banford, Samantha; Burlina, Alberto B.; et al.; Galactose epimerase deficiency: lessons from the GalNet registry; BioMed Central; Orphanet Journal Of Rare Diseases; 17; 1; 12-2022; 1-12
1750-1172
CONICET Digital
CONICET
url http://hdl.handle.net/11336/213633
identifier_str_mv Derks, Britt; Demirbas, Didem; Arantes, Rodrigo R.; Banford, Samantha; Burlina, Alberto B.; et al.; Galactose epimerase deficiency: lessons from the GalNet registry; BioMed Central; Orphanet Journal Of Rare Diseases; 17; 1; 12-2022; 1-12
1750-1172
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/s13023-022-02494-4
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614200274452480
score 13.070432